Humacyte to Present at the Piper Sandler 35th Annual Healthcare Conference

<p>DURHAM, N.C., Nov. 24, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced that Laura Niklason, M.D., Ph.D., Founder, President, and Chief Executive Officer, and Dale Sander, Chief Financial Officer, will present at the Piper Sandler 35th Annual Healthcare Conference, […]</p>
<p>The post <a href="https://forextv.com/top-news/humacyte-to-present-at-the-piper-sandler-35th-annual-healthcare-conference/">Humacyte to Present at the Piper Sandler 35th Annual Healthcare Conference</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>